Difference between revisions of "Biphenotypic sinonasal sarcoma"

From Libre Pathology
Jump to navigation Jump to search
(create)
 
Line 20: Line 20:
*Actin +ve.
*Actin +ve.
*S-100 +ve (strong).
*S-100 +ve (strong).
==Molecular==
*PAX3-MAML3 fusion - t(2;4)(q35;q31.1).<ref name=pmid24859338>{{Cite journal  | last1 = Wang | first1 = X. | last2 = Bledsoe | first2 = KL. | last3 = Graham | first3 = RP. | last4 = Asmann | first4 = YW. | last5 = Viswanatha | first5 = DS. | last6 = Lewis | first6 = JE. | last7 = Lewis | first7 = JT. | last8 = Chou | first8 = MM. | last9 = Yaszemski | first9 = MJ. | title = Recurrent PAX3-MAML3 fusion in biphenotypic sinonasal sarcoma. | journal = Nat Genet | volume = 46 | issue = 7 | pages = 666-8 | month = Jul | year = 2014 | doi = 10.1038/ng.2989 | PMID = 24859338 }}</ref>


==See also==
==See also==

Revision as of 16:08, 13 March 2016

Biphenotypic sinonasal sarcoma is a rare bland appearing malignant tumour of the head and neck.

It is also known as low grade sinonasla sarcoma with neural and myogenic features, abbreviated LGSSNMF.

General

  • Rare.
  • Female predominant.

Microscopic

Features;

  • Bland hypercellular stroma typically without many mitoses.
  • Invaginating glandular epithelium.

DDx:

IHC

  • Actin +ve.
  • S-100 +ve (strong).

Molecular

  • PAX3-MAML3 fusion - t(2;4)(q35;q31.1).[1]

See also

References

  1. Wang, X.; Bledsoe, KL.; Graham, RP.; Asmann, YW.; Viswanatha, DS.; Lewis, JE.; Lewis, JT.; Chou, MM. et al. (Jul 2014). "Recurrent PAX3-MAML3 fusion in biphenotypic sinonasal sarcoma.". Nat Genet 46 (7): 666-8. doi:10.1038/ng.2989. PMID 24859338.